Atlas Trials

Safety of Transarterial Chemoembolization (TACE) in the Setting of an Elevated Bilirubin

Clinical trial NCT03259581 · COMPLETED

Trial details

NCT number
NCT03259581
Sponsor
University of Minnesota
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Hepatocellular CarcinomaBilirubinemia
Start date
2018-01-02
Primary completion
2021-12-31
Enrollment
5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.